Oral MK-677 altered the ratio of GH isoforms, increasing non-22kDa and 20kDa GH variants relative to standard 22kDa GH, suggesting GH secretagogues produce a different GH profile than exogenous GH injections.
Different GH typesMK-677 increased non-standard GH isoforms (20kDa, non-22kDa) — GH secretagogues don't just raise GH, they change the TYPES of GH produced
What the researchers found
MK-677 treatment increased the proportion of non-22kDa and 20kDa GH isoforms relative to total GH in obese subjects, demonstrating that GH secretagogues alter the GH isoform profile differently from exogenous GH replacement.
Why it matters
Different GH isoforms may have different biological effects (growth, fat metabolism, etc.). If MK-677 produces a unique GH isoform mix, its clinical effects may differ from standard GH injections in subtle but important ways.
How the study worked
Clinical trial substudy from the MK-677 body composition study. GH isoform analysis using size-exclusion HPLC and immunoassays in obese males during 8-week MK-677 treatment.
What this study cannot tell us
Isoform analysis in one study population. The clinical significance of altered isoform ratios is unknown.
How to read the evidence
Moderate evidence from a clinical study with specialized GH isoform analysis, revealing a previously unappreciated pharmacological dimension.
When this study was published
Published in 2003. GH isoform biology has been further studied but remains incompletely understood.
The bigger picture
GH pharmacology is more nuanced than total GH levels suggest. The isoform composition may determine which biological effects dominate — a dimension missed by standard GH assays.
Questions still open
- Do different GH isoforms have different biological activities?
- Does the altered isoform profile explain any unique MK-677 effects?
- Should GH isoforms be monitored during GH secretagogue therapy?
Common questions
Is all growth hormone the same?
Does this matter clinically?
Read the original research
The effect of treatment with the oral growth hormone (GH) secretagogue MK-677 on GH isoforms.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 13(1), 1-7
Citation
Svensson, J; Boguszewski, C L; Shibata, F; Carlsson, B; Carlsson, L M S; Bengtsson, B-A. (2003). The effect of treatment with the oral growth hormone (GH) secretagogue MK-677 on GH isoforms.. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 13(1), 1-7.